GBA1 and Parkinson disease: These findings align with the clinical data presented by Gan‐Or et al., which demonstrated that individuals with severe GBA1 mutations associated with PD present with a more severe phenotype, characterized by earlier onset of symptoms and more pronounced motor, psychiatric, cognitive, and olfactory deficits (Gan‐Or et al., 2008, 2009).